COMMUNIQUÉS West-GlobeNewswire
-
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
10/05/2024 - 15:00 -
Healthcare Integrated Technologies, Inc. Welcomes Ryan Holland to its Board of Directors
10/05/2024 - 15:20 -
Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation
10/05/2024 - 15:35 -
CannaCon West Coming to the Albuquerque Convention Center in May 2024
10/05/2024 - 15:35 -
KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence
10/05/2024 - 16:58 -
ACTG SLIM LIVER Findings Published in Annals of Internal Medicine
10/05/2024 - 17:13 -
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
10/05/2024 - 12:00 -
Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Programs and Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
10/05/2024 - 12:00 -
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
10/05/2024 - 12:00 -
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
10/05/2024 - 12:30 -
Le TAR-200 en monothérapie montre un taux de réponse complète supérieur à 80 pour cent chez les patients atteints d’un cancer de la vessie n’infiltrant pas le muscle à haut risque
10/05/2024 - 12:43 -
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
10/05/2024 - 12:50 -
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
10/05/2024 - 13:00 -
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
10/05/2024 - 13:00 -
Humacyte First Quarter 2024 Financial Results and Business Update
10/05/2024 - 13:00 -
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
10/05/2024 - 13:00 -
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
10/05/2024 - 13:00 -
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
10/05/2024 - 13:00 -
Apertura Gene Therapy Showcases Advancements in Capsid Engineering Platform in Presentations at ASGCT Annual Meeting
10/05/2024 - 13:00
Pages